For 2015, the editors of Chain Drug Review have chosen to give the publication’s annual Retailer of the Year honors to two chain drug retail industry leaders: Stefano Pessina, executive vice chairman and CEO of Walgreens Boots Alliance Inc., and the management team at Rite Aid Corp., led by chairman and CEO John Standley. Pessina’s
CAMP HILL, Pa. — Rite Aid Corp. stockholders will vote next month on the company’s merger with Walgreens Boots Alliance (WBA). Rite Aid has scheduled a February 4 special stockholders meeting for the balloting. Stockholders as of the close of business on December 18 will be eligible to vote. Rite Aid and WBA also announced
Christmas is over, yesterday’s news. And the mass retailing community is scampering to assess its impact on sales, earnings and the future. For chain drug retailers, this holiday selling season, like so many before it, was acceptable, if hardly record-setting. As in previous years, America’s drug chains suffered from an absence of exciting new products
CAMP HILL, Pa. — Rite Aid Corp. posted fiscal 2016 third-quarter adjusted earnings in line with Wall Street estimates and announced a special shareholders meeting to vote on its $17.2 billion deal to be acquired by Walgreens Boots Alliance Inc. Rite Aid said Thursday that for the third quarter ended Nov. 28, net income totaled
CAMP HILL, Pa. — With its recent acquisitions, Rite Aid Corp. is well-positioned to further expand its health care capabilities, according to chairman and chief executive officer John Standley. The company in June closed the $2 billion acquisition of Envision Pharmaceutical Services, which brought the EnvisionRx pharmacy benefit manager (PBM) as well as specialty pharmacy,
The National Association of Chain Drug Stores held its year-end meetings in New York City early this month — and very little was as it had been a year ago. Many of the same familiar faces were on hand, and several of the same retail companies attended. But the yearlong series of events that have
DEERFIELD, Ill. — The consolidation of chain drug retailing climaxed last month with Walgreens Boots Alliance Inc.’s (WBA’s) acquisition of Rite Aid Corp. In the largest outright purchase of a chain in the industry’s history, WBA agreed to acquire Rite Aid for $9 per share, or $17.2 billion, including debt. The price represents a premium
CAMP HILL, Pa. — Darren Karst has been promoted to the combined role of senior executive vice president, chief financial officer and chief administrative officer at Rite Aid Corp. Karst, who joined Rite Aid in August 2014 as the company’s executive vice president and chief financial officer, is assuming the chief administrative officer responsibilities currently
CAMP HILL, Pa. — It’s been an impressive journey for Rite Aid Corp. Not long ago, Rite Aid was a struggling drug chain, laden with debt and unable to keep pace with larger, fast-growing competitors. But today, under a firmer financial footing, the $26.5 billion company stands as a profitable, innovative industry leader, widening its
DEERFIELD, Ill., and CAMP HILL, Pa. — After headlines surfaced earlier in the day, Walgreens Boots Alliance Inc. made it official: The company has reached a deal to acquire Rite Aid Corp. for a total value of $17.2 billion. The companies announced the deal late Tuesday. Under the agreement, Walgreens Boots Alliance will buy Rite
As the year 2015 winds down, the chain drug community must face the reality that the coming year will be unlike any that has preceded it. The same drug chains still rule the U.S. landscape. But the content of their character and the face of the people who guide them are vastly different than in
CAMP HILL, Pa. — To celebrate American Pharmacist Month, Rite Aid Corp. has launched its annual “Vote for Your Favorite Pharmacy Team Member Contest.” The drug chain said Thursday that the contest, which runs to Oct. 31, gives customers a chance to win $2,500 in Rite Aid gift cards by nominating a favorite member of
CAMP HILL, Pa. — A new chapter opened for Rite Aid Corp. in its fiscal 2016 second quarter, as the company began reporting financial results under a new structure that incorporates recently acquired pharmacy benefit manager (PBM) EnvisionRx. Going forward, Rite Aid will report results in two business segments: retail pharmacy (including Rite Aid drug
CAMP HILL, Pa. — Rite Aid Corp. saw revenue surge in its fiscal 2016 second quarter, its first including results for recently acquired pharmacy benefit manager EnvisionRx. Rite Aid said Thursday that sales for the second quarter ended Aug. 29 totaled $7.66 billion, up 17.5% from $6.52 billion a year earlier. For the first time,
